why choose us

Clinical Trials Search

Showing 15,860 of 132,656 result(s)
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions

Status: Completed

Condition: Chronic Pelvic Pain Syndrome

Interventions: Tone is a binary measurement of the pelvic floor muscle on physical examination

Date: 2023-01-20

CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission

Status: Completed

Condition: B Acute Lymphoblastic Leukemia

Interventions: Given IV

Date: 2023-01-20

tDCS and Impulsivity

Status: Completed

Condition: Substance Use Disorders

Interventions:

EEG: The tKIWI uses sensors placed on specific locations of the head for the EEG reading.

tDCS: The anode and cathode are two large 5 cm by 5

Date: 2023-01-20

Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)

Status: Completed

Condition: Snakebite

Interventions: This is a lyophilized drug contained in 100 mg vials to be reconstituted in Water for Injection (WFI), followed by dilution into 0.9% Sodium Chloride

Date: 2023-01-20

Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

Status: Completed

Condition: Sarcoma

Interventions:

Date: 2023-01-20

Evaluation of the Pharmacokinetics and Safety of VX 548 in Participants With Renal Impairment

Status: Completed

Condition: Pain

Interventions: Tablets for oral administration.

Date: 2023-01-19

3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer

Status: Completed

Condition: Breast Carcinoma

Interventions: Undergo 3D-US

Date: 2023-01-19

Switching to E-cigarettes in African-American Smokers

Status: Completed

Condition: Smoking Reduction

Interventions: 0.5 mg once daily for days 1-3, 0.5mg twice daily for days 4-7 and 1.0 mg twice daily from day 8 through week 12.

Date: 2023-01-19

Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine

Status: Completed

Condition: Response To Dengue Exposure

Interventions: The rDEN3delta30;31-7164 vaccine is a live attenuated virus constructed by creating two deletions in the 3 UTR of the DENV3 Sleman;78 strain

Date: 2023-01-19

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Status: Completed

Condition: Psoriatic Arthritis

Interventions: Dose A VTX958

Date: 2023-01-19